Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%
MT Newswires
Feb 06
JinYao Global, a subsidiary of Tianjin Pharmaceutical Da Ren Tang's (SGX:T14) controlling shareholder, Tianjin Pharmaceutical, acquired additional S-Shares in the company at $2.96 apiece for $242,953, according to a Thursday filing with the Singapore Exchange.
Shares of the pharmaceutical company were up over 3% in Friday trading.
JinYao acquired 82,200 S-shares, representing around 0.0107% of the company's issued share capital. Following the acquisition of the new shares, the controlling shareholder's stake has increased to 43.008%.
Meanwhile, JinYao Global has proposed to increase the shareholding further within six months, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.